Cannara Biotech's total liabilities is $69M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Cannara Biotech (LOVE.V) currently reports a total liabilities of $69M as of May 2026. That compares with $71M in the prior-year period — down 4.0% year over year. Use the charts on this page to explore Cannara Biotech's total liabilities history and peer comparisons.
Cannara Biotech's total liabilities decreased from $71M to $69M — a 4.0% year-over-year decrease (period ending May 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Cannara Biotech reported $69M in total liabilities as of May 2026. That compares with $71M in the prior-year period — down 4.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total liabilities of $69M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cannara Biotech, and consider following LOVE.V for alerts when major investors trade the stock.